Overview
- IR-Sant Pau announced Esteller will establish and lead a new group focused on applied epigenetics, personalized medicine and translational oncology.
- The institute says his leadership will help attract competitive funding, recruit high-level scientists and deepen international research networks.
- Reporting indicated he had been preparing to join The James Comprehensive Cancer Center in Ohio on December 6, a move averted by this recruitment.
- He left the Institut Josep Carreras in October following an independent audit that the center said found funds were, in some cases, directed to different research lines than intended.
- He has denied wrongdoing and was removed from the IJC directorship in June 2024 after complaints were filed with the Oficina Antifrau and the CIR-CAT.